| Financial Year |
March 31 2023 |
| Monetary Funds |
12,571,873,718.60 |
| Held-for-trading Financial Assets |
411,058.40 |
| Notes Receivable |
442,208,898.90 |
| Accounts Receivable |
1,627,798,197.15 |
| Advances to Suppliers |
140,834,107.72 |
| Other Receivables |
115,614,702.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,400,782,179.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
800,000.00 |
| Other Current Assets |
39,453,205.63 |
| Total Current Assets |
21,470,965,643.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,127,106.74 |
| Long-term Equity Investment |
19,096,818.05 |
| Investment Properties |
664,081.99 |
| Fixed Assetes |
3,798,988,820.20 |
| Under-construction Projects |
107,678,186.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
3,925,064.31 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
738,446,521.88 |
| R&D expenses |
-- |
| Goodwill |
44,259,643.31 |
| Long-Term Deferred and Prepaid Expenses |
101,871,029.31 |
| Deferred Income Tax Assets |
219,351,294.64 |
| Other Non-Current Assets |
60,157,818.57 |
| Sub-Total of Non-Current Assets |
6,443,371,937.94 |
| Total Assets |
27,914,337,581.53 |
| Short-Term Loans |
299,741,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,870,976.38 |
| Accounts Payable |
3,545,445,345.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
492,499,513.76 |
| Taxes Payable |
311,167,483.54 |
| Interest Payable |
-- |
| Dividend Payable |
12,871,969.13 |
| Other payables |
490,431,930.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
463,660,358.94 |
| Other Current Liabilities |
68,147,039.79 |
| Sub-Total of Current Liabilities |
6,389,010,184.68 |
| Long-term Loans |
1,221,791,388.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
9,135,740.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
8,672,738.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,300,194,233.27 |
| Total Liabilities |
8,689,204,417.95 |
| Paid-In Capital(Or Share Stock) |
1,371,470,262.00 |
| Capital Surplus |
2,008,891,613.89 |
| Surplus Reserve |
1,078,713,423.89 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,789,008,028.76 |
| Minority Stockholder's Interest |
6,916,608,606.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,308,524,557.01 |
| Owner's Equity（Stockholder's Equity） |
19,225,133,163.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
27,914,337,581.53 |
